Nasal Spray Treatment for Depression
Unlike traditional antidepressants, Spravato supports your brain’s natural pathways.
- 1000+Successful Therapies
- FlatironEasy to Access Location
- Board-CertifiedPsychiatrist
Highly Recommended
High Success Rate
A clinical study on patients with treatment-resistant depression found that combining an oral antidepressant with intranasal esketamine led to significant improvement. In the study, 70% of patients who received this combination showed improvement, compared to just over 50% who received a placebo
Want to learn more about Spravato treatment?
Contact Us
Spravato
As part of a treatment plan, your psychiatrist will determine if the treatment should be used alone or with an oral antidepressant. This will be done under medical supervision through the SPRAVATO® REMS program.
Contact UsDr. Omidvari on Spravato
Watch a two-minute segment on how Spravato works, filmed at our Flatiron office.
What We Treat with Spravato
-
Treatment-Resistant Depression (TRD)
-
Major Depressive Disorder (MDD)
-
Anxiety with Comorbid Depression
Key Benefits
-
Fully Insurance-CoveredPrior authorization handled by our team.
-
Rapid System ReliefDesigned for fast-acting mental clarity.
-
Non-Surgical & Needle-LessA comfortable, non-invasive experience.
The Clinical Setup: Engineered for Safety and Comfort
Our dedicated environment ensures your advanced treatment is safe, peaceful, and restorative.
- Private Rooms
- Zero-Gravity Chairs
- Direct Medical Supervision
All Major Insurances Accepted
We make treatment easy and accessible by providing comprehensive superbills for potential out-of-network insurance reimbursement.
Not sure if this is the right fit for you?
Let’s connect for a quick, free phone consultation.
Contact Us
Important safety information
Spravato (esketamine). Spravato carries an FDA Boxed Warning for sedation; dissociation; potential for abuse and misuse; and suicidal thoughts and behaviors. It is a Schedule III controlled substance available only through a restricted program (Spravato REMS). Patients are monitored for at least 2 hours after each dose and must not drive until the next day after restful sleep. Common side effects include dissociation, dizziness, nausea, sedation, vertigo, anxiety, and increased blood pressure. Spravato is not right for everyone; your psychiatrist will decide if it's appropriate.